http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-329398-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-62 |
| filingDate | 1966-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31b416a062307378d981d16d51677c94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f24cf2ee03f0dea871fdac518933675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ecbb500e124bb97bb0ad06a263fc97 |
| publicationDate | 1970-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SE-329398-B |
| abstract | 1,159,271. Anti-inflammatory &c., medicines. TAKEDA CHEMICAL INDUSTRIES Ltd. 20 July, 1966 [21 July, 1965; 7 May, 1966], No. 32641/66. Heading A5B [Also in Division C2] Pharmaceutical compositions having antiinflammatory and uricosuric activity comprise, as active ingredient, at least one 1,5-disubstituted barbituric acid derivative of the general formula wherein R 1 is a S - hydroxy - n - butyl, α - hydroxy - n - butyl or α - carboxypropyl group and R 2 is a cyclohexyl or phenyl group, or pharmaceutically acceptable base addition salt thereof, optionally together with aminopyrine or a steroidal anti-inflammatory agent and optionally together with a pharmaceutically acceptable carrier therefor. The compositions may be administered orally, rectally or parenterally. |
| priorityDate | 1965-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.